India records 21% decline in TB incidence and treatment coverage rises to 92% (See 'Corp Brief') India has moved from following the World to moving alongside it in Science and Technology: MoS (See 'Corp Brief') Yadav underlines scaled-up Climate Finance, Technology Transfer and Capacity-building (See 'Corp Brief') IPR - If defendant adopts mark that is minor phonetic and visual manipulation of well-known registered trademark, coupled with identical colour scheme, get-up, and trade dress, strong prima facie case of trademark & copyright infringement is made out: HC (See 'Legal Desk') CCI approves acquisition of 100% shareholding of Vishavari Tollway by Concessoc 41 SAS (See 'Corp Brief') CCI okays acquisition of sole control over Omega-Meyer by BCPE Wellbeing Holdco Two Ltd (See 'Corp Brief') CCI approves acquisition of equity in Prestige Hospitality Ventures Limited by CPP Investment Board (See 'Corp Brief') Central Zoo Authority and IIFM inaugurate 3-Day Regional Training Programme for Zookeepers at IIFM, Bhopal (See 'Corp Brief') CCI approves proposed combination related to internal restructuring of JSW Group (See 'Corp Brief') RRM Inaugurates SAREX-2026 as 24th NMSAR Board Meeting reviews Maritime SAR Preparedness (See 'Corp Brief') NLMC organises mock E-Auction Training ahead of RINL Land E-Auction (See 'Corp Brief') India, Ghana sign historic MoU to advance Agricultural Research and Technology Transfer (See 'Corp Brief') COP31 should focus on closing Gaps and fulfilling Commitments: Yadav (See 'Corp Brief') CBN conducts Jan Samvad at Malana in Kullu District to create preventive drug awareness (See 'Corp Brief') IBC - Per Section 9 of IBC, where operational debt meets statutory threshold & no pre-existing dispute exists, then application for initiation of CIRP is maintainable: NCLT (See 'Legal Desk') Switzerland Sees India as Emerging Global R&D Power, Earmarks CHF 45 Million for Science and Technology Partnership (See 'Corp Brief') Textile Council To Form Working Groups To Address Sector Challenges (See 'Corp Brief') President Murmu urges AIIMS Bilaspur graduates to serve in Himachal's remote, rural areas (See 'Corp Brief') Banks told to expand digital lending, financial inclusion outreach: DFS secretary (See 'Corp Brief') SEBI - Allegation of violations of SEBI (Prohibition of Fraudulent and Unfair Trade Practices relating to Securities Market) Regulations is serious & cannot be sustained on mere general allegations, individual perceptions, or violations of investment advisory regulations alone: SAT (See 'Legal Desk') Union renewable energy minister will inaugurate Windergy India 2026 in Chennai on Oct 8 (See 'Corp Brief') Kasturi Cotton gains traction as India puts traceability on the textile map (See 'Corp Brief') IPR - Visual deceptive similarity, phonetic identity, likelihood of public confusion, brand dilution, and misrepresentation of association are sufficient to justify interim injunctive relief: HC (See 'Legal Desk') Dr. Jitendra Singh Pushes Digital Pension Services for Ease of Life (See 'Corp Brief') CIL steps up coal supplies to power plants amid availability concerns (See 'Corp Brief') SARFAESI Act, 2002 - Writ remedy under Article 226 cannot be used to bypass or circumvent this designated statutory remedy & specialized forum, which is uniquely equipped to assess the intricacies of such proceedings: HC (See 'Legal Desk') G20 Trade Ministers reach Consensus against Weaponization of Food through Coercive Trade Actions (See 'Corp Brief') Robotics to become accelerating tool in Every Specialty of Medicine: MoS (See 'Corp Brief') NITI Aayog organises National Workshop on SDG Budgeting in Kolkata (See 'Corp Brief') IPR - Fraudulent mobile applications deceptively imitating Plaintiff's branding and falsely projecting themselves as official investment platforms, deserves to be taken down: HC (See 'Legal Desk') First Tigress in Buxa Tiger Reserve released under Tiger Reintroduction Programme (See 'Corp Brief') CBN destroys over 10.84 tonnes of seized narcotic drugs (See 'Corp Brief') CRIT and IIFT organise three-day Orientation Course on Trade Negotiations (See 'Corp Brief') APEDA Facilitates FPO-led Export of Frozen Food Products from Haryana to Canada (See 'Corp Brief') PMLA - Provisional attachment invalid where material at hand does not show how in absence of provisional attachment, the properties could be so disposed off so as to frustrate confiscation proceedings: SAFEMA Tribunal (See 'Legal Desk') An unsuccessful 'success fee' litigation (See CORP EINSICHT)

Print

Glenmark's Swiss arm gets nod to market Ryaltris nasal spray in Russia

Published: Feb 22, 2021

By TIOLCORPLAWS News Service

NEW DELHI, FEB 22, 2021: GLENMARK Pharmaceuticals on Monday said its Swiss subsidiary, Glenmark Specialty, has received marketing approval from Russian health regulators for its fixed-dose combination nasal spray, Ryaltris.

Ryaltris is indicated for symptomatic treatment of seasonal and perennial allergic rhinitis, like stuffy and runny nose, nasal itching, sneezing, as well as irritated eyes, in adults and children over 12 years of age.

"Glenmark has built strong capabilities in the area of respiratory medicine and is among the leading players in this therapy area across several markets globally. Russia is one of the key markets for us and we are consistently looking to expand our product portfolio," said Csaba Kantor, Senior Vice President - Russia and CIS region, Glenmark.

In Russia, allergic rhinitis affects 10-20 per cent of the population on average, with certain regions having a higher prevalence rate of 18-38 per cent.

"Glenmark has a strong established presence in Russia for over 30 years, which will enable us to lead the commercialization of this product in the country. We look forward to being able to make this innovative product available to patients in Russia as soon as possible," Mr Kantor added.

The company estimated that Ryaltris will be available to patients in Russia by the first quarter of 2021-22.

TIOL CORP SEARCH

TIOL GROUP WEBSITES

taxindiaonline
taxindiainternational
TKF
TIOLawards
A TIOL Website. Copyright © 2025 TIOLcorplaws.com All rights reserved.